Navigation Links
Azantis Announces New Consumer Safety Program
Date:10/7/2010

BOULDER, Colo., Oct. 7 /PRNewswire/ -- Marine biotechnology specialist Azantis, Inc. has made a new post-marketing surveillance program available to its clients, in an effort to provide continued high quality service to the consumer.  By entering into an agreement with SafetyCall International, Azantis has partnered with the recognized leader in Adverse Event Management and Post-Market Surveillance services.

SafetyCall medical and toxicology professionals are recognized experts in the collection and interpretation of spontaneously reported incident data.  For the past 25 years, SafetyCall professionals managed over 1.5 million product incident cases, positively impacting the safety of products worldwide.

As a client of SafetyCall, Azantis invites all its clients to place the SafetyCall number on their finished product labels.  In the event of a complaint, incident, or adverse event, the consumer calls the number.  SafetyCall medical professionals engage the consumer, to better understand the nature of the complaint—often interacting directly with the consumer's personal physician.  This depth of case management helps consumers assess whether the event is truly attributable to the product.  Krill oil consumers benefit from the free service, because they can quickly access a medical professional familiar with this class of products, who can address their safety concerns. Azantis krill oil resellers benefit from this service, because they share a strong common safety record, and have an independent professional service assisting them with evaluating any possible adverse medical incident.  

With over 100 million capsules sold, Azantis has an exemplary safety record as krill oil supplier, with no adverse events attributed to its products.  Azantis' bulk krill oil has GRAS (Generally Recognized as Safe) notification status from the Food and Drug Administration.  Our agreement with SafetyCall will formalize our post-market surveillance system and serve as a program that meets the new FDA regulatory requirements.

About Azantis:

Azantis is a biotechnology company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products.  Azantis' product offerings include bulk krill oil and bulk krill oil capsules, which contain high quality marine phospholipids with bonded omega-3 fatty acids, esterified astaxanthin, and choline.  Azantis krill oil is derived from krill sustainably harvested under the supervision of the international treaty organization CCAMLR (Convention on the Conservation of Antarctic Marine Living Resources).

www.azantis.com


'/>"/>
SOURCE Azantis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants
2. NCPA Announces Exhibit Hall Activities for 2010 NCPA Annual Convention and Trade Exposition
3. Onyx Pharmaceuticals Announces Teleconference to Provide Status Update on Carfilzomib
4. Nonin Medical Announces Its Second-Generation Wrist-Worn Device for European Distribution: Delivering Reliability in the Widest Range of Patient Populations and Clinical Settings
5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
6. SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
7. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2010 Results
9. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
10. Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets
11. Orthopedics This Week Announces 2010 Best Spine Technology Award Winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- M ichael Moore ... Chairman   Mission Therapeutics, a drug discovery and ... treat cancer, neurodegenerative and other diseases, announces that Dr ... January 1 st 2017. Dr Colin Goddard ... in July 2015. Michael Moore , Mission,s Founder Chairman, ...
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)... , Dec. 3, 2016  Results from the ... SelG1), an anti-P-selectin antibody, reduced the median annual rate ... to placebo (1.63 vs 2.98, p=0.010) in patients with ... that the data are being featured in the official ... of Hematology (ASH) Annual Meeting and presented during the ...
Breaking Medicine Technology:
(Date:12/5/2016)... Lakes, NJ (PRWEB) , ... December 05, 2016 ... ... recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” Gibson ... Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus , ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... moisture measurements are consistently correct. However, regular performance testing is often neglected ... offers a solution: SmartCal™ . This innovative test substance offers a ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):